List of Tables
Table 1. Global Sclerotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Detergents
Table 3. Major Companies of Osmotic Agents
Table 4. Major Companies of Chemical Irritants
Table 5. Global Sclerotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Sclerotherapy Market Size by Region (US$ Million): 2022 VS 2028
Table 7. Global Sclerotherapy Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Sclerotherapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 9. Sclerotherapy Revenue by Company (2017-2022) & (US$ Million)
Table 10. Sclerotherapy Revenue Share by Company (2017-2022)
Table 11. Ranking of Global Top Sclerotherapy Players by Revenue (US$ Million) in 2021
Table 12. Global Sclerotherapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 13. Global Sclerotherapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sclerotherapy as of 2021)
Table 14. Global Sclerotherapy Companies Headquarters
Table 15. Global Sclerotherapy Companies Product & Service
Table 16. Date of International Companies Enter into Sclerotherapy Market
Table 17. Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
Table 18. BTG Corporation Information
Table 19. BTG Description and Business Overview
Table 20. BTG Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 21. BTG Sclerotherapy Product
Table 22. BTG Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 23. BTG Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 24. BTG Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 25. BTG Recent Development
Table 26. Kreussler Corporation Information
Table 27. Kreussler Description and Business Overview
Table 28. Kreussler Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 29. Kreussler Sclerotherapy Product
Table 30. Kreussler Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 31. Kreussler Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 32. Kreussler Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 33. Kreussler Recent Development
Table 34. LGM Pharma Corporation Information
Table 35. LGM Pharma Description and Business Overview
Table 36. LGM Pharma Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 37. LGM Pharma Sclerotherapy Product
Table 38. LGM Pharma Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 39. LGM Pharma Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 40. LGM Pharma Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 41. LGM Pharma Recent Development
Table 42. Troikaa Corporation Information
Table 43. Troikaa Description and Business Overview
Table 44. Troikaa Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 45. Troikaa Sclerotherapy Product
Table 46. Troikaa Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 47. Troikaa Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 48. Troikaa Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 49. Troikaa Recent Development
Table 50. Changan Tianyu group Corporation Information
Table 51. Changan Tianyu group Description and Business Overview
Table 52. Changan Tianyu group Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 53. Changan Tianyu group Sclerotherapy Product
Table 54. Changan Tianyu group Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 55. Changan Tianyu group Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 56. Changan Tianyu group Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 57. Changan Tianyu group Recent Development
Table 58. Bioniche Pharma Group Ltd Corporation Information
Table 59. Bioniche Pharma Group Ltd Description and Business Overview
Table 60. Bioniche Pharma Group Ltd Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 61. Bioniche Pharma Group Ltd Sclerotherapy Product
Table 62. Bioniche Pharma Group Ltd Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 63. Bioniche Pharma Group Ltd Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 64. Bioniche Pharma Group Ltd Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 65. Omega Pharmaceuticals Corporation Information
Table 66. Omega Pharmaceuticals Description and Business Overview
Table 67. Omega Pharmaceuticals Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 68. Omega Pharmaceuticals Sclerotherapy Product
Table 69. Omega Pharmaceuticals Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 70. Omega Pharmaceuticals Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 71. Omega Pharmaceuticals Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 72. Angiodynamics Corporation Information
Table 73. Angiodynamics Description and Business Overview
Table 74. Angiodynamics Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 75. Angiodynamics Sclerotherapy Product
Table 76. Angiodynamics Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 77. Angiodynamics Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 78. Angiodynamics Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 79. ENDO-FLEX Corporation Information
Table 80. ENDO-FLEX Description and Business Overview
Table 81. ENDO-FLEX Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 82. ENDO-FLEX Sclerotherapy Product
Table 83. ENDO-FLEX Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 84. ENDO-FLEX Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 85. ENDO-FLEX Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 86. MTW ENDOSKOPIE Corporation Information
Table 87. MTW ENDOSKOPIE Description and Business Overview
Table 88. MTW ENDOSKOPIE Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 89. MTW ENDOSKOPIE Sclerotherapy Product
Table 90. MTW ENDOSKOPIE Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 91. MTW ENDOSKOPIE Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 92. MTW ENDOSKOPIE Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 93. Cook Medical Corporation Information
Table 94. Cook Medical Description and Business Overview
Table 95. Cook Medical Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 96. Cook Medical Sclerotherapy Product
Table 97. Cook Medical Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
Table 98. Cook Medical Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
Table 99. Cook Medical Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
Table 100. Global Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 101. Global Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 102. Global Sclerotherapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 103. North America Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 104. North America Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 105. North America Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 106. North America Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 107. Asia-Pacific Sclerotherapy Revenue by Region (2017-2028) & (US$ Million)
Table 108. Asia-Pacific Sclerotherapy Revenue by Region (2023-2028) & (US$ Million)
Table 109. Asia-Pacific Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 110. Asia-Pacific Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 111. Europe Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 112. Europe Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 113. Europe Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 114. Europe Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 115. Latin America Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 117. Latin America Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 118. Latin America Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 121. Middle East and Africa Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 123. Sclerotherapy Key Raw Materials, Industry Status and Trend
Table 124. Sclerotherapy Key Raw Materials and Upstream Suppliers
Table 125. Sclerotherapy Clients Status and Trend
Table 126. Sclerotherapy Typical Clients
Table 127. Sclerotherapy Distributors
Table 128. Sclerotherapy Market Trends
Table 129. Sclerotherapy Market Drivers
Table 130. Sclerotherapy Market Challenges
Table 131. Sclerotherapy Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Sclerotherapy Product Picture
Figure 2. Global Sclerotherapy Revenue Market Share by Type in 2021 & 2028
Figure 3. Detergents Product Picture
Figure 4. Osmotic Agents Product Picture
Figure 5. Chemical Irritants Product Picture
Figure 6. Global Sclerotherapy Revenue Market Share by Application in 2021 & 2028
Figure 7. Venous Disease
Figure 8. Gastrointestinal Bleeding
Figure 9. Bronchopleural Fistula
Figure 10. Cystic Disease
Figure 11. Sclerotherapy Report Years Considered
Figure 12. Global Sclerotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Sclerotherapy Market Size 2017-2028 (US$ Million)
Figure 14. Global Sclerotherapy Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Sclerotherapy Revenue Market Share by Region (2017-2028)
Figure 16. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Sclerotherapy Revenue Market Share Forecast by Type (2017-2028)
Figure 18. Global Sclerotherapy Revenue Market Share Forecast by Application (2017-2028)
Figure 19. North America Sclerotherapy Revenue 2017-2028 (US$ Million)
Figure 20. North America Sclerotherapy Revenue Market Share by Type (2017-2022)
Figure 21. North America Sclerotherapy Revenue Market Share by Application (2017-2022)
Figure 22. Asia-Pacific Sclerotherapy Revenue 2017-2028 (US$ Million)
Figure 23. Asia-Pacific Sclerotherapy Revenue Market Share by Region (2017-2028)
Figure 24. Asia-Pacific Sclerotherapy Revenue Market Share by Type (2017-2022)
Figure 25. Asia-Pacific Sclerotherapy Revenue Market Share by Application (2017-2022)
Figure 26. Europe Sclerotherapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 27. Europe Sclerotherapy Revenue Market Share by Country (2017-2028)
Figure 28. Europe Sclerotherapy Revenue Market Share by Type (2017-2022)
Figure 29. Europe Sclerotherapy Revenue Market Share by Application (2017-2022)
Figure 30. Latin America Sclerotherapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 31. Latin America Sclerotherapy Revenue Market Share by Country (2017-2022)
Figure 32. Latin America Sclerotherapy Revenue Market Share by Type (2017-2022)
Figure 33. Latin America Sclerotherapy Revenue Market Share by Application (2017-2022)
Figure 34. Middle East and Africa Sclerotherapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Middle East and Africa Sclerotherapy Revenue Market Share by Country (2017-2028)
Figure 36. Middle East and Africa Sclerotherapy Revenue Market Share by Type (2017-2022)
Figure 37. Middle East and Africa Sclerotherapy Revenue Market Share by Application (2017-2022)
Figure 38. Sclerotherapy Supply Chain (Upstream and Downstream Market)
Figure 39. Global Production Market Share of Sclerotherapy Raw Materials by Region in 2021
Figure 40. Sclerotherapy Distribution Channels
Figure 41. Global Sclerotherapy Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 42. Global Sclerotherapy Percentage 2017-2028: Online Sales VS Offline Sales
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed